Drugs / TVGV-1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02576561 | Nov 2015 → May 2018 | cervical intraepithelial neoplasia grade 2/3, human papilloma virus infection | THEVAX Genetics Vaccine | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TVGV-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02576561 ↗ |
| Modality | Vaccine | “investigational study vaccine, called TVGV-1” NCT02576561 ↗ |